Imaging biomarkers for the diagnosis and prognosis of back pain and related conditions

Patent metadata

Field	Value
Publication number	US-10638948-B2
Application number	US-201414785235-A
Country	US
Kind code	B2
Filing date	Apr 18, 2014
Priority date	Apr 19, 2013
Publication date	May 5, 2020
Grant date	May 5, 2020

Abstract

The present invention teaches novel methods of diagnosing and prognosing conditions associated with tissue degeneration and/or pain, including intervertebral disc degeneration, discogenic pain, osteoarthritis, rheumatoid arthritis, and articular cartilage injury. Using the inventive noninvasive imaging methods, the diagnosis and prognosis of back pain and related conditions can be quickly and accurately determined by detecting one or more biomarkers disclosed herein.

First claim

What is claimed is:

1. A method for diagnosing a subject with the presence or absence of a condition characterized by tissue degeneration and/or pain, comprising:
performing a scan of a region of the subject's body using a magnetic resonance imaging (MRI) scanner;
generating an image of the region of the subject's body from the performed scan using Reduced-Field-of-View Turbo-Spin-Echo Chemical Exchange Saturation Transfer (rFOV TSE CEST) imaging,
wherein the Reduced-Field-of-View Turbo-Spin-Echo Chemical Exchange Saturation Transfer (rFOV TSE CEST) imaging comprises moving gradients of 180° refocusing pulses from a slice-encoding direction to a phase-encoding direction to obtain a reduced field of view;

processing the image to detect one or more biomarkers within the image of the region,
wherein the biomarkers are selected from the group consisting of pH, glycosaminoglycan (GAG) concentration, glucose concentration, and lactate concentration; and
diagnosing the subject with the presence or absence of the condition based upon the biomarkers detected within the image of the region of the subject's body.

2. The method of claim 1 , wherein the image of the region of the subject's body comprises a joint or an intervertebral disc.

3. The method of claim 1 , wherein the condition is selected from the group consisting of: intervertebral disc degeneration, discogenic pain, osteoarthritis, rheumatoid arthritis, an articular cartilage injury, tempromandibular disc degeneration and combinations thereof.

4. The method of claim 1 , wherein the biomarkers are selected from pH and glycosaminoglycan (GAG) concentration.

5. The method of claim 1 , wherein the subject is diagnosed with the condition if the biomarkers detected from scanning indicate one or more abnormal physiological states within the image of the region compared to a subject without the condition.

6. The method of claim 5 , further comprising determining that an origin of the subject's pain associated with the condition is within the region of the subject's body where the abnormal physiological state is detected.

7. The method of claim 1 , wherein a slice thickness for the MRI scan is selected so as to avoid fat signal interference.

8. The method of claim 7 , wherein the slice thickness is 3 mm.

9. The method of claim 1 , wherein the MRI scanner is a 3.0T MRI scanner.

10. The method of claim 1 , wherein the image is a CEST image.

11. A method for prognosing a condition associated with tissue degeneration and/or pain in a subject, comprising:
performing a scan of a region of the subject's body using a magnetic resonance imaging (MRI) scanner;
generating an image of the region of the subject's body from the performed scan using Reduced-Field-of-View Turbo-Spin-Echo Chemical Exchange Saturation Transfer (rFOV TSE CEST) imaging,
wherein the Reduced-Field-of-View Turbo-Spin-Echo Chemical Exchange Saturation Transfer (rFOV TSE CEST) imaging comprises moving gradients of 180° refocusing pulses from a slice-encoding direction to a phase-encoding direction to obtain a reduced field of view;

processing the image to detect one or more biomarkers within the image of the region,
wherein the biomarkers are selected from the group consisting of pH, glycosaminoglycan (GAG) concentration, glucose concentration, and lactate concentration; and

prognosing the condition by comparing measurements of one or more biomarkers detected within the image of the region to previous measurements of the same one or more biomarkers detected within the image of the region.

12. The method of claim 11 , wherein the condition is selected from the group consisting of: intervertebral disc degeneration, discogenic pain, osteoarthritis, rheumatoid arthritis, an articular cartilage injury, tempromandibular disc degeneration and combinations thereof.

13. The method of claim 11 , wherein the image of the region of the subject's body comprises a joint or an intervertebral disc.

14. The method of claim 11 , wherein the biomarkers are selected from pH and glycosaminoglycan (GAG) concentration.

15. The method of claim 11 , wherein a slice thickness for the MRI scan is selected so as to avoid fat signal interference.

16. The method of claim 15 , wherein the slice thickness is 3 mm.

17. The method of claim 11 , wherein the image is a CEST image.

18. A method for determining an extent of intervertebral disc (IVD) degeneration in a subject, comprising:
performing a scan of a region of interest in the subject using a magnetic resonance imaging (MRI) scanner,
generating an image of the region of interest from the performed scan using Reduced-Field-of-View Turbo-Spin-Echo Chemical Exchange Saturation Transfer (rFOV TSE CEST) imaging,
wherein the Reduced-Field-of-View Turbo-Spin-Echo Chemical Exchange Saturation Transfer (rFOV TSE CEST) imaging comprises moving gradients of 180° refocusing pulses from a slice-encoding direction to a phase-encoding direction to obtain a reduced field of view, and
wherein the region of interest comprises an intervertebral disc;

obtaining an —OH chemical exchange saturation transfer (—OH CEST) signal from the MRI scan; and
determining the extent of IVD degeneration in the subject,
wherein a lower —OH CEST signal, compared to normal, indicates disc degeneration, and wherein the lower the —OH CEST signal is, the greater the extent of IVD degeneration determined.

19. The method of claim 18 , wherein a slice thickness for the MRI scan is selected so as to avoid fat signal interference.

20. The method of claim 19 , wherein the slice thickness is 3 mm.

21. A method for identifying a painful intervertebral disc (IVD) in a subject, comprising:
performing a scan of a region of interest in the subject using a magnetic resonance imaging (MRI) scanner;
generating an image of the region of interest from the performed scan using Reduced-Field-of-View Turbo-Spin-Echo Chemical Exchange Saturation Transfer (rFOV TSE CEST) imaging,
wherein the Reduced-Field-of-View Turbo-Spin-Echo Chemical Exchange Saturation Transfer (rFOV TSE CEST) imaging comprises moving gradients of 180° refocusing pulses from a slice-encoding direction to a phase-encoding direction to obtain a reduced field of view, and
wherein the region of interest comprises an intervertebral disc;

determining R 1ρ dispersion and —OH CEST in the region of interest; and
identifying a painful IVD in the subject based upon the ratio of R 1ρ dispersion and —OH CEST (RROC), wherein a painful disc is determined if an RROC value is high compared to normal.

22. The method of claim 21 , wherein the MRI scanner is a 3.0T MRI scanner.

23. The method of claim 21 , wherein a slice thickness for the MRI scan is selected so as to avoid fat signal interference.

24. The method of claim 23 , wherein the slice thickness is 3 mm.

25. A method for determining an extent of intervertebral disc (IVD) regeneration in a subject, comprising:
performing a scan of a region of interest in the subject using a magnetic resonance imaging (MRI) scanner,
generating an image of the region of interest from the performed scan using Reduced-Field-of-View Turbo-Spin-Echo Chemical Exchange Saturation Transfer (rFOV TSE CEST) imaging,
wherein the Reduced-Field-of-View Turbo-Spin-Echo Chemical Exchange Saturation Transfer (rFOV TSE CEST) imaging comprises moving gradients of 180° refocusing pulses from a slice-encoding direction to a phase-encoding directio

Assignees

• Cedars Sinai Medical Center

Inventors

• Gazit Dan
• Li Debiao
• Bae Hyun
• Pelled Gadi
• Gazit Zulma
• Liu Qi
• Tawackoli Wafa

Classifications

• A61B5/407

  Evaluating the spinal cord (for locating the epidural space A61B5/4896) · CPC title

• A61B5/14539

  for measuring pH · CPC title

• A61B5/14546

  for measuring analytes not otherwise provided for, e.g. ions, cytochromes · CPC title

• A61B5/4566

  Evaluating the spine (A61B5/4561 takes precedence) · CPC title

• A61B5/004 Primary

  adapted for image acquisition of a particular organ or body part (A61B5/0082 takes precedence; arrangements for optical scanning A61B5/0062) · CPC title